People channel feed – Endpoints News

People channel feed

After a legendary stint at Celgene's helm, biopharma vet Bob Hugin is on his way out — as Senate race rumors swirl

8 years ago

Heptares co-founder Fiona Marshall grabs the helm at Merck's upcoming UK drug discovery center

8 years ago

Shire CEO Flemming Ornskov is hatching a few new stretch goals for R&D in 2018 — and beyond

8 years ago

Pfizer oncology head Liz Barrett jumps ship to Novartis as Bruno Strigini steps aside

8 years ago

What break? Sarepta vet Ed Kaye quickly pivots to the helm of another biotech upstart with a $40M bankroll

8 years ago

John Mendlein steps in to help focus on the big picture at a fast-growing Moderna

8 years ago

Biogen vet Jean-Paul Kress takes the reins at NYC's Syntimmune

8 years ago

AbbVie vet John Leonard moves up to the helm at CRISPR/Cas9 pioneer Intellia, focused on looming human studies

8 years ago

Grail taps Genentech vet Jennifer Cook as CEO, building expectations for 2018

8 years ago

Novartis oncology CEO Bruno Strigini is calling it quits

8 years ago

SEC charges Provectus founding CEO Dees with looting millions for girlfriends’ cosmetic surgeries, travel and more

8 years ago

Sexual harassment in biotech hits home as OrbiMed’s Sam Isaly steps down in wake of STAT report

8 years ago

Looking for the next big breakthrough in CAR-T, Mike Gilman debuts Obsidian with $49.5M round

8 years ago

Michael Pellini has just joined Bill Maris at Section 32 — focused on patient care and drug development

8 years ago

Stealthy Silverback recruits Seattle Genetics’ Eric Dobmeier as CEO, filling C-suite with oncology talent

8 years ago

CRISPR/Cas9 pioneer Chad Cowan enlists in Mustang Bio’s CAR-T quest

8 years ago

Shire CEO Ornskov woos Bayer’s Andreas Busch to run Boston-based R&D group

8 years ago

In reorganization, Joerg Moeller gathers all the pharma R&D reins at Bayer as discovery chief exits

8 years ago

Looking to cure Type 1 diabetes, investors front $114M to launch a pioneering human study at Semma

8 years ago

Doug Williams ups the ante at Codiak Bio to $168.5M in a drive to first human study

8 years ago

After building a rep as an architect of experiments, RxCelerate plants its flag in America

8 years ago

Synthetic biology pioneer Synthorx recruits Cleave's Laura Shawver for top position

8 years ago

Roiled by financial turmoil, Teva's CEO boots R&D chief, top execs in C-suite overhaul

8 years ago

Six top biotech VCs take a look at the latest trends, and offer their thoughts on 2018

8 years ago

First page Previous page 90 91 929394 95 96 Next page Last page